Claims for Patent: 7,745,494
✉ Email this page to a colleague
Summary for Patent: 7,745,494
Title: | Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy |
Abstract: | The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin. |
Inventor(s): | Perez-Soler; Roman (New York, NY), Ling; Yi-He (Briarwood, NY) |
Assignee: | Albert Einstein College of Medicine of Yeshiva University (Bronx, NY) |
Application Number: | 11/886,803 |
Patent Claims: | 1. A method for treating a skin rash secondary to an anti-epidermal growth factor receptor (EGFR) therapy in a subject receiving said therapy, the method comprising applying
vitamin K3 to the skin in an amount effective to treat the skin rash.
2. The method of claim 1, wherein the anti-EGFR therapy is treatment with an anti-EGFR antibody. 3. The method of claim 2, wherein the anti-EGFR antibody is cetuximab. 4. The method of claim 1, wherein the anti-EGFR therapy is treatment with an EGFR tyrosine kinase inhibitor. 5. The method of claim 4, wherein the EGFR tyrosine kinase inhibitor is gefitinib or erlotinib. 6. The method of claim 1, wherein the vitamin K3 activates EGFR. 7. The method of claim 1, wherein the vitamin K3 is formulated in a pharmaceutical formulation suitable for topical administration. 8. The method of claim 1, wherein the vitamin K3 is applied to the face. 9. The method of claim 1, wherein the vitamin K3 is applied to the trunk. 10. The method of claim 1, comprising exposing skin cells to 0.01 mM vitamin K3. 11. The method of claim 1, comprising exposing skin cells to 15 mM vitamin K3. 12. The method of claim 1, comprising exposing skin cells to 30 mM vitamin K3. 13. The method of claim 1, comprising exposing skin cells to 100 mM vitamin K3. 14. The method of claim 1, comprising applying the vitamin K3 twice daily. 15. The method of claim 1, comprising applying vitamin K3 daily. 16. The method of claim 1, comprising applying the vitamin K3 every other day. |
Details for Patent 7,745,494
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 02/12/2004 | ⤷ Try a Trial | 2025-04-15 |
Eli Lilly And Company | ERBITUX | cetuximab | Injection | 125084 | 03/28/2007 | ⤷ Try a Trial | 2025-04-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.